ISTA Pharmaceuticals, Inc. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360° view of the company.
Detailed information on ISTA Pharmaceuticals, Inc. required for business and competitor intelligence needs
A study of the major internal and external factors affecting ISTA Pharmaceuticals, Inc. in the form of a SWOT analysis
An in-depth view of the business model of ISTA Pharmaceuticals, Inc. including a breakdown and examination of key business segments
Intelligence on ISTA Pharmaceuticals, Inc.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about ISTA Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
ISTA Pharmaceuticals (ISTA) is an ophthalmic pharmaceutical company engaged in the development and commercialization of products for the treatment of inflammation, ocular pain, glaucoma, allergy and dry eye. The company primarily operates in the US. It is headquartered in Irvine, California and employed 326 people as of January 31, 2011. The company recorded revenues of $156.5 million during the financial year (FY) ended December 2010, an increase of 41.5% over FY2009. The operating profit of the company was $10.4 million during FY2010, as compared to an operating profit of $2.1 million in FY2009. The net loss was $5.3 million in FY2010, as compared to a net loss of $57.8 million in FY2009.
Reasons to Purchase:
Gain understanding of ISTA Pharmaceuticals, Inc. and the factors that influence its strategies
Track strategic initiatives of the company and latest corporate news and actions
Assess ISTA Pharmaceuticals, Inc. as a prospective partner, vendor or supplier
Support sales activities by understanding your customers' businesses better
Stay up to date on ISTA Pharmaceuticals, Inc.’s business structure, strategy and prospects